Skip to main content

Table 1 Main clinical process of the first case co-infected by avian influenza A H7N9 and mycoplasma pneumoniae in Kaili, Guizhou province, China

From: Clinical characteristics from co-infection with avian influenza A H7N9 and Mycoplasma pneumoniae: a case report

Course

Date

Clinical major events

day 1

5 January, 2017

Fever, cough, abdominal distention, weakness, anorexia

day 7

11 January, 2017

Went to see doctor, and sputum and throat swabs were collected to be checked for the presence of avian influenza virus

day 9

13 January, 2017

Admitted to Second Affiliated Hospital of Guizhou Medical University, CT scan showed obvious consolidation and infiltration in bilateral lungs and ground-glass changes in upper area of right lung; and she was diagnosed with pneumoniae, Oseltamivir and meropenem were administered

day 10

14 January, 2017

Result of neucleic acid testing for H7N9 was positive and the patient was transferred to ICU because of illness deterioration and ARDS. Non-invasive MV. Titer of antibody to mycoplasma pneumoniae was 1:80;

day 14

18 January, 2017

CHest X-ray showed the infectious focus of bilateral lung partially absorbed.

day 15

19 January, 2017

Cough again with fewer sputum, other symptoms exacerbated again, increase of moist rale in upper area in right lung; Titer of antibody to mycoplasma pneumoniae rised to 1:160;

day 19

23 January, 2017

CT scan showed new focus appearing in upper aera while old infultration being absorbed. Titer of antibody to mycoplasma pneumoniae arrived to 1:640, and azithromycin and moxifloxacin were administered.

day 19

23 January, 2017

Oseltamivir was discontinued because of three continual examinations of neucleic acid for influenza A H7N9 changed to negative

day 22

26 January, 2017

CT scan shground-glass focus enlarged comparing to that at 12 days before.

day 25

29 January, 2017

The titer of the antibody decreased to 1:320.Patient’s symptoms were alleviated and moist rales reduced

day 32

4 February, 2017

CT scan revealed the right upper focus obviously absorbed. Moxifloxacin was discontinued while azithromycin was till continued.

day 33

5 February, 2017

Discharged from hospital.

day 35

7 February, 2017

Titier of antibody to M. pneumoniae decreased to 1:80.

day 41

13 February, 2017

All symptoms disappeared and azithromycin discontinued.